Kuriakose Emil
Chief Medical Officer
Kuriakose Emil has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: May 5, 2026.
On the most recent filing, Kuriakose Emil is listed as Chief Medical Officer at Terns Pharmaceuticals, Inc. Inside the rolling window, Kuriakose Emil reported no open-market purchases and 3 open-market sales totaling $102K in TERN. The largest disclosed transaction in the window is a sale of 942 TERN shares on Apr 1, 2026, worth $50K.
Companies traded
Other insiders at TERN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$102K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kuriakose Emil made?
Kuriakose Emil has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.
Which companies does Kuriakose Emil trade?
Kuriakose Emil has filed SEC Form 4 disclosures for 1 company, including TERN.
When was Kuriakose Emil's most recent SEC Form 4 filing?
Kuriakose Emil's most recent SEC Form 4 filing on Tracefour is dated May 5, 2026.
What is Kuriakose Emil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kuriakose Emil is listed as Chief Medical Officer.
What is Kuriakose Emil's total buy and sell value in the current window?
Inside the rolling retention window, Kuriakose Emil bought $0 and sold $102K based on SEC Form 4 filings.
What was Kuriakose Emil's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 942 TERN shares on 2026-04-01, worth $50K, per SEC Form 4 filings.